• Home >>
  • Pharmaceuticals and Healthcare >>
  • Aptamer Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Aptamer Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 233115 15th May, 2018 Region : Global Pages Reports Monitor

Aptamer Market


Market Scenario:-

 Aptamer market  is defined as short biomolecules like peptides and oligonucleotides that bind to specific targets with extremely high affinity based on their structural conformations. Aptamers plays an important role in the field of life science and have been extensively researched for application as therapeutic agents, analytical tools and as vehicles for targeted drug delivery. 

 Market trends includes R&D investments in pharmaceutical and biotechnology industries, technological advancements, low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the aptamers market and the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX). Aptamer products can be used as diagnostics, biosensors, research agents, or can be considered as a tool for biomarker or discovery of drug. Owing to higher research, investment in biotechnological and pharmaceutical companies and higher research, Global Aptamers market is witnessing the positive growth. Moreover, the factors which affects the Aptamer market relates to ethical issues in using aptamers, stringent regulations in use of aptamers and slow in reaching market place. The increase in application of aptamers in the chemical and food industries are expected to create large opportunities for market growth.

Market Segment:- 

Global Aptamers Market is segmented on the basis of  application, type, end user, Technology and region. On the basis of application, the market is segmented into Therapeutics, Research and Development and Diagnostics. On the basis of type ,the market is segmented on the basis of Nucleic acid Aptamers and peptide Aptamers. On the basis of Region, the market is segmented into size, share, insights, opportunity Analysis and Industry forecast. And on the basis of technology the market is segmented into SELEX and other technologies.


Regional Analysis:-

Geographically, Aptamers market is classified into regions like Middle east and Africa, North Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, North America, Japan. Europe and North America will remain key markets for Aptamers market. Owing to presence of key players in the market, Europe region is expected to witness strong growth. Asia Pacific is anticipated to register positive growth owing to increased opportunities in diagnostics and development of pharmaceuticals which are remain untapped in the aptamers market.


Key Players:-

 AM Biotechnologies LLC

 Aptagen LLC

 Aptamer Sciences In

 TriLink BioTechnologies Inc

 Aptamer Solutions Ltd

 Base Pair Biotechnologies Inc

 Aptus Biotech S.L

 SomaLogic Inc


Aptamer market segmentation:-


By types:-

 Nucleic Acid Aptamers

 DNA-Based Aptamers

 RNA-Based Aptamers

 XNA-Based Aptamers

 Peptide Aptamers


By Applications:-

• Research and Development

• Diagnostics

• Therapeutics Development


By end users:-

• Bio-Pharmaceutical companies 

• Contract Research Organization

• Pharmaceutical Companies

• Academic and Research centres


By technology:-

• SELEX


By Regions:-

• Asia Pacific (China, India, ASEAN, Australia & New Zealand 

• North America (U.S., Canada)

• Latin America (Mexico, Brazil and Rest of Latin America)

• Eastern Europe (Poland, Russia and Rest of Eastern Europe)

• Middle East and Africa (GCC, S. Africa, and Rest of MEA)

Research Scope

 

The study for Global Aptamer Market will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2018 to 2025

The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 

Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 

The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

 

1. Introduction

1.1. Market Definition

1.2. Market Scope


2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions


3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 


4. Type Overview

4.1. Introduction

4.2. Market Size & Forecast, 2015 to 2025

4.2.1. Nucleic Acid Aptamers

4.2.2. DNA-Based Aptamers

4.2.3. RNA-Based Aptamers

4.2.4. XNA-Based Aptamers

4.2.5. Peptide Aptamers

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Application Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. Research and Development

5.2.2. Diagnostics

5.2.3. Therapeutics Development

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. End-User Overview

6.1. Introduction

6.2. Market Size & Forecast, 2015 to 2025

6.2.1. Bio-Pharmaceutical companies 

6.2.2. Contract Research Organization

6.2.3. Pharmaceutical Companies

6.2.4. Academic and Research centers

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. Technology Overview

7.1. Introduction

7.2. Market Size & Forecast, 2015 to 2025

7.2.1. SELEX

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Regional Overview

8.1. Introduction

8.2. Market Size & Forecast, 2015 to 2025

8.2.1. North America

8.2.1.1. U.S.

8.2.1.2. Canada

8.2.1.3. Mexico 

8.2.2. Europe

8.2.2.1. UK

8.2.2.2. Germany

8.2.2.3. France

8.2.2.4. Italy 

8.2.2.5. Spain

8.2.2.6. Rest of Europe

8.2.3. Asia-Pacific

8.2.3.1. China

8.2.3.2. India

8.2.3.3. Japan

8.2.3.4. South Korea

8.2.3.5. Rest of Asia-Pacific

8.2.4. LAMEA

8.2.4.1. Brazil

8.2.4.2. UAE

8.2.4.3. South Africa

8.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


9. Manufacturer/ Vendor Profile

9.1. The following attributes will be considered while profiling key manufacturers in this industry: 

9.1.1. Company Overview

9.1.2. Financial Synopsis

9.1.3. Recent Developments

9.1.4. R&D Investments (if any)

9.1.5. Strategy Overview (Analyst Perspective)

9.1.6. Product Portfolio

9.2. Companies Profiled

9.2.1. AM Biotechnologies LLC

9.2.2. Aptagen LLC

9.2.3. Aptamer Sciences In

9.2.4. TriLink BioTechnologies Inc

9.2.5. Aptamer Solutions Ltd

9.2.6. Base Pair Biotechnologies Inc

9.2.7. Aptus Biotech S.L

9.2.8. SomaLogic Inc

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]